Looking at those results, common sense suggests that sir-spheres should be included in first line therapy for those whose cancer has only spread to the liver. An additional 7.9 months of progression free survival in the liver.
ASCO, page-17
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 17.5¢ | $81.83K | 467.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3898006 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 2478662 | 37 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| SRX (ASX) Chart |